Yi‐Hsiung Lin
-
- Metabolism, Diabetes, and Cancer 3
- Synthesis and bioactivity of alkaloids 3
- Hepatology top 10%
- Toxicology top 10%
-
- Cardiovascular Function and Risk Factors 5
- Atrial Fibrillation Management and Outcomes 3
-
- Diabetes Treatment and Management 5
-
- melanin and skin pigmentation 3
-
- Autophagy in Disease and Therapy 3
-
- Effects of Vibration on Health 2
Yi‐Hsiung Lin
50 papers receiving 1.2k citations
Hit Papers
Peers
Comparison fields: 5 of 118
- Molecular Biology 666
- Cancer Research 129
- Hepatology 61
- Horticulture 7
- Toxicology 20
Countries citing papers authored by Yi‐Hsiung Lin
This map shows the geographic impact of Yi‐Hsiung Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yi‐Hsiung Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yi‐Hsiung Lin more than expected).
Fields of papers citing papers by Yi‐Hsiung Lin
This network shows the impact of papers produced by Yi‐Hsiung Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yi‐Hsiung Lin. The network helps show where Yi‐Hsiung Lin may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Yi‐Hsiung Lin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 4 | |
| 2 | 2023 | 3 | |
| 3 | 2023 | 1 | |
| 4 | 2023 | 13 | |
| 5 | 2023 | 7 | |
| 6 | 2023 | 10 | |
| 7 | 2023 | 5 | |
| 8 | 2022 | 4 | |
| 9 | 2022 | 16 | |
| 10 | Inflammation-related pyroptosis, a novel programmed cell death pathway, and its crosstalk with immune therapy in cancer treatmentbreakdown → | 2021 | 336 |
| 11 | 2020 | 10 | |
| 12 | 2019 | 15 | |
| 13 | 2011 | 50 | |
| 14 | 2011 | 29 | |
| 15 | 2011 | 21 | |
| 16 | 2006 | 55 | |
| 17 | 2006 | 39 | |
| 18 | 2006 | 38 | |
| 19 | 2005 | 32 | |
| 20 | 2004 | 1 |
About Yi‐Hsiung Lin
Yi‐Hsiung Lin is a scholar working on Physiology, Cardiology and Cardiovascular Medicine and Endocrinology, Diabetes and Metabolism, having authored 50 papers that have together received 1.2k indexed citations. Recurring topics across this work include Cardiovascular Function and Risk Factors (5 papers), Diabetes Treatment and Management (5 papers), Atrial Fibrillation Management and Outcomes (3 papers), Metabolism, Diabetes, and Cancer (3 papers), Synthesis and bioactivity of alkaloids (3 papers), melanin and skin pigmentation (3 papers), Autophagy in Disease and Therapy (3 papers) and Effects of Vibration on Health (2 papers). The work is most often cited by research in Molecular Biology (666 citations), Cancer Research (129 citations) and Hepatology (61 citations). Yi‐Hsiung Lin has collaborated with scholars based in Taiwan, United States and China. Frequent co-authors include Chien‐Chih Chiu, Kai‐Chun Cheng, Chia‐Hung Yen, Sheng‐Kai Hsu, Chia‐Yang Li, I‐Ling Lin, Yen‐Ni Teng, Yih‐Fung Chen, Sheng‐Huei Yang and Shinne‐Ren Lin. Their work appears in journals such as Proceedings of the National Academy of Sciences, PLoS ONE and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.